g Biomedical Open Access Journal For Medical and Clinical Research | Biomedres.us
  info@biomedres.us   +1 (720) 414-3554   600 Third Avenue, 2nd floor, New York - 10016, USA
ISSN: 2574 -1241
Impact Factor 0.548

Review ArticleOpen Access

Therapeutic Innovations in Cancer, Review

Volume 8 - Issue 5

Hajra Haneef1*, Nazar-ul-Islam2 and Khalid Mahmood2

  • Author Information Open or Close
    • 1Ex-student of Quaid-e-Azam University, Islamabad,Pakistan
    • 2Biological Production Division, National Institute of Health, Chak shahzad, Pakistan

    *Corresponding author: Hajra Haneef, Student of College of Medical Laboratory Technology, Chak Shehzad, Islamabad, Pakiatan, Tel: +923326485485; Email: 272hajra@gmail.com

Received: August 30, 2018;   Published: September 10, 2018

DOI: 10.26717/BJSTR.2018.08.001721

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Therapies in field of tumor are still new. A lot of avenues have to discover, various are still in non-clinical trials. Some achieve success in their targets in clinical fields. But now, the time turn, for production of vaccine against cancer and their trials on human. No doubt, this production is time consuming and expensive treatment in these days, but as it progress, it will be in human victory as like other medications. Hence, Cancer vaccines represent a promising avenue for cancer immunotherapy.

Keywords: Cancer; Monoclonal Antibodies; Adoptive Therapy; Vaccines

Abstract | Introduction | Cancer Immunotherapy | Monoclonal Antibodies | Immune Checkpoint Therapy | Adoptive Cancer Therapy: | The Current Manuscript is Focused Primarily on Vaccine Therapy | Viruses in Tumor World | Bacteria in Field of Cancer | Nanoparticle (Liposome, Quantum Dot, and Dendrimer)-Mediated Cancer Therapy | Conclusion | Future Prospects | References |